Safety and Utilization of Blood Components as Therapeutic Delivery Systems

Author(s): Tiffany Adams, Fars Alanazi, D. Robert Lu

Journal Name: Current Pharmaceutical Biotechnology

Volume 4 , Issue 5 , 2003

Become EABM
Become Reviewer
Call for Editor


In recent years, natural blood components have been extensively studied as the advanced therapeutic delivery systems. The blood components which can potentially be used as the therapeutic delivery systems include different types of cells, such as erythrocytes and lymphocytes, macromolecular complexes such as lipoproteins and antibody or albumin conjugates and other molecules. This review article covers the progress in this topic, specifically, including the safety issues and the utilization of these component. It can be seen through the literature that the blood components as the therapeutic delivery systems have a number of advantages over traditional pharmaceutical products. The efficacy and practice of the applications, however, require significant amount of development work in the near future.

Keywords: therapeutic delivery systems, erythrocytes, lymphocytes, macromolecular complexes, lipoproteins

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2003
Published on: 01 March, 2012
Page: [275 - 282]
Pages: 8
DOI: 10.2174/1389201033489720
Price: $65

Article Metrics

PDF: 3